Table of contents

Research Article

• Requirements for safety and quality of intravenous immunoglobulin G preparations. (1 November, 1994)

  G H Rütter
• Immunomodulating effects of intravenous immunoglobulin in autoimmune and inflammatory diseases. (1 November, 1994)

  S V Kaveri, L Mouthon, M D Kazatchkine
• Receptors for gammaglobulin in the central and peripheral nervous system. (1 November, 1994)

  C Vedeler, E Ulvestad, H Nyland, R Matre, J A Aarli
• Intravenous immunoglobulin therapy in multiple sclerosis: progress from remyelination in the Theiler's virus model to a randomised, double-blind, placebo-controlled clinical trial. (1 November, 1994)

  J H Noseworthy, P C O'Brien, B G van Engelen, M Rodriguez
• In vitro effects of polyvalent immunoglobulin for intravenous use. (1 November, 1994)

  I N van Schaik, M Vermeulen, A Brand
• The impact of the intracerebral antibody response on the clinical course of a virus-induced demyelination in a rat model system. (1 November, 1994)

  R Dörries, H Imrich, A Hein, S Czub, S Schwender
• Passage of intravenous immunoglobulin and interaction with the CNS. (1 November, 1994)

  U Wurster, J Haas
• Gangliosides and autoimmune neuropathies: classification and clinical aspects of autoimmune neuropathies. (1 November, 1994)

  A J Steck, L Kappos
• Electrophysiological sequels of inflammatory demyelination. (1 November, 1994)

  W A Nix
• The Guillain-Barré syndrome: plasma exchange or immunoglobulins intravenously. (1 November, 1994)

  F G van der Meché
• Clinical and neurophysiological assessment of immunoglobulin therapy in five patients with multifocal motor neuropathy. (1 November, 1994)

  G Comi, S Amadio, G Galardi, R Fazio, R Nemni
• Intravenous immunoglobulin treatment in patients with chronic inflammatory demyelinating polyneuropathy. (1 November, 1994)

  P A van Doorn
• Intravenous immunoglobulin treatment in patients with chronic inflammatory demyelinating neuropathy not responsive to other treatments. (1 November, 1994)

  R Nemni, S Amadio, R Fazio, G Galardi, S Previtali, G Comi
• Human immunoglobulin treatment of multifocal motor neuropathy and polyneuropathy associated with monoclonal gammopathy. (1 November, 1994)

  J M Leger, A B Younes-Chennoufi, B Chassande, G Davila, P Bouche, N Baumann, P Brunet
• Indications for intravenous gammaglobulin therapy in inflammatory myopathies. (1 November, 1994)

  P Cherin, S Herson
• Experience with intravenous immunoglobulin in myasthenia gravis: a review. (1 November, 1994)

  G Edan, F Landgraf
• Intravenous gammaglobulin treatment in multiple sclerosis and experimental autoimmune encephalomyelitis: delineation of usage and mode of action. (1 November, 1994)

  A Achiron, R Gilad, R Margalit, U Gabbay, I Sarova-Pinhas, I R Cohen, E Melamed, O Lider, S Noy, I Ziv
• Treatment of multiple sclerosis with IVIg: potential effects and methodology of clinical trials. (1 November, 1994)

  P S Sørensen
• Promotion of remyelination by polyclonal immunoglobulin in Theiler's virus-induced demyelination and in multiple sclerosis. (1 November, 1994)

  B G van Engelen, D J Miller, K D Pavelko, O R Hommes, M Rodriguez
• High dose immunoglobulin IV treatment in adrenoleukodystrophy. (1 November, 1994)

  M Cappa, E Bertini, P del Balzo, P Cambiaso, A Di Biase, S Salvati
• Immunoglobulin treatment in human and experimental epilepsy. (1 November, 1994)

  B G van Engelen, W O Renier, C M Weemaes